Physician profile
Sidney Rabinowitz
NPI 1043272081
$4,595.97
in general payments reported to CMS, 2019-2025
24 companies · $1,202 in 2025
The $1,202 reported for 2025 was more than what 77% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $558 · 2021: $82.36 · 2022: $200 · 2023: $448 · 2024: $1,907 · 2025: $1,202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,993 · Long Term Medical Supply Or Device Loan: $1,565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,992.59 |
| Long Term Medical Supply Or Device Loan | $1,565.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,948.86 | 2019-2025 | Integra, Amnioexcel, Primatrix |
| Seapearl East, INC | $665.04 | 2020-2024 | |
| Abbvie INC. | $291.23 | 2023-2025 | |
| Tela Bio, INC. | $233.26 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kerecis Limited | $217.99 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Checkpoint Surgical, INC | $208.51 | 2022-2023 | Checkpoint Stimulators |
| Dilon Technologies, INC. | $162.61 | 2024 | Hemoblast Bellows |
| Axogen | $144.58 | 2019-2025 | |
| Sanara Medtech INC. | $143.12 | 2024 | Celleraterx |
| Smith+Nephew, INC. | $140.51 | 2020-2025 | Pico 7, Collagenase Santyl |
| Endo Pharmaceuticals INC. | $115.49 | 2019-2023 | Xiaflex |
| Kci USA, INC. | $42.02 | 2019-2022 | |
| Sientra, INC. | $33.25 | 2019 | |
| Galderma Laboratories, L.P. | $31.01 | 2021-2024 | Dysport |
| Endo USA, INC. | $30.85 | 2024 | Xiaflex |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $30.57 | 2025 | |
| Biowound Solutions, INC. | $29.13 | 2025 | Bio-Connekt |
| Rti Surgical, INC | $28.77 | 2023 | |
| Acera Surgical, INC. | $22.45 | 2025 | Restrata Wound Matrix |
| Zimvie INC. | $18.04 | 2022 | |
| Convatec INC. | $16.18 | 2024 | |
| Allergan, INC. | $15.16 | 2021 | |
| Zimmer Biomet Holdings, INC. | $13.76 | 2019 | |
| Solventum Corporation | $13.58 | 2024 | Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sidney Rabinowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.